Limba
|
AG-13958 (AG-013958), a VEGFRtyrosine kinase inhibitor, is in clinical development with ST administration for treatment of choroidal neovascularization associated with age–related macular degeneration (AMD).
Price | 1.372,00 RON (preturile sunt fara TVA) |
---|---|
Description |
AG-13958 (AG-013958), a VEGFRtyrosine kinase inhibitor, is in clinical development with ST administration for treatment of choroidal neovascularization associated with age–related macular degeneration (AMD). |